GoodRx’s brand new CEO, Wendy Barnes, says her job is not so much to fix anything, but to speed up the company’s current ...

Healthcare tech company GoodRx (NASDAQ:GDRX) in Q4 CY2024, with sales flat year on year at $198.6 million. On the other hand, ...

As a reminder, today's call is being recorded. I would now like to introduce your host for today's call, Aubrey Reynolds, ...

Women Spent $8.8 Billion More than Men in 2024, with Women Ages 18-44 Facing the Steepest Out-of-Pocket Cost Disparity GoodRx (Nasdaq: GDRX), the leading platform for medication savings in the U.S ...

Wells Fargo lowered the firm’s price target on GoodRx (GDRX) to $8 from $9 and keeps an Overweight rating on the shares. The firm says that ...

SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx Holdings, Inc. (Nasdaq: GDRX) ("we," "us," "our," “GoodRx,” or the “Company”), the leading prescription savings ...

Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx fourth-quarter and full-year 2024 earnings call. As a reminder, today's call is being recorded. I would now like to ...

Ladies and gentlemen, thank you for standing by, and welcome to the GoodRx Fourth Quarter and Full Year 2024 Earnings Call. As a reminder, today's call is being recorded. I would now like to ...